-
Cantor Fitzgerald Reiterates "Overweight" Rating for Cidara Therapeutics (NASDAQ:CDTX)
Source: Buzz FX / 27 Jan 2025 10:26:19 America/New_York
Cantor Fitzgerald Reiterates "Overweight" Rating for Cidara Therapeutics (NASDAQ:CDTX) Written by MarketBeat January 27, 2025 Share Link copied to clipboard. Cidara Therapeutics ( NASDAQ:CDTX - Get Free Report ) 's stock had its "overweight
Read more...